OBJECTIVES The relative contribution of heart failure (HF) compared with other medical and nonmedical factors on diminished quality of life (QOL) across subtypes with reduced, better, and preserved left ventricular ejection fraction (LVEF) in a large ambulatory HF population was evaluated.
T he increasing prevalence and evolving profile of chronic heart failure (HF) have increased awareness of the importance of incorporating patient-centered outcomes, including quality of life (QOL), in routine ambulatory care (1) . Patients with HF and related conditions predisposing to HF, including myocardial infarction, diabetes, and obesity, are living longer in the setting of more advanced therapies and interventions and frequently rate improved QOL as more important than longer survival (2) . HF has a significant negative impact on all aspects of health-related QOL, particularly those related to physical functioning, mental health, and social domains (3) (4) (5) . Even compared with other serious cardiac or noncardiac chronic conditions, impairment in QOL is greatest in patients with HF, determined largely by New York Heart Association (NYHA) functional class (5, 6) . Reduced QOL has been consistently associated with worse prognosis in patients with HF, predictive of both rehospitalization and mortality (7) (8) (9) (10) .
Although many current HF therapies have had a positive impact on QOL, major limitations in QOL often persist in patients with HF (11) . The degree of QOL limitation has been shown to be similar across HF populations with preserved or reduced left ventricular ejection fraction (LVEF) (4, 12) . However, in the contemporary complex and aging HF population, with patients often carrying significant burdens of associated cardiac and noncardiac comorbid conditions (13, 14) , multiple factors beyond HF may influence patients' perceptions of their QOL. Despite this, little is known about the relative contributions of other medical comorbidities and even nonmedical factors on QOL impairment in patients with HF.
Meanwhile, the success of current medical and device therapies has created a new HF population distinct from those with HF with reduced LVEF (HFrEF) and HF with preserved LVEF (HFpEF), composed of patients with previously reduced but now improved LVEFs to $50%, or HF with better LVEF (HFbetterEF) (15, 16) . Although frequently misclassified as having HFpEF, these patients are both clinically and biochemically distinct, with a lower comorbidity profile, milder HF symptom burden, and lower event rate than patients with either HFpEF or HFrEF (15, 16) .
We hypothesized that given the heterogeneity in functional status across HF subtypes, heterogeneity may also arise in patients' perceived dominant limitations to their QOL; patients with HF may be equally or predominantly limited in their QOL by superimposed disease or even independent factors. Accordingly, the principal aim of the present study was to determine the contribution of HF compared with medical and nonmedical factors to patients' perceived dominant limitations to their overall health-related QOL and its clinical correlates in a large, ambulatory HF population including patients with HFrEF, those with HFpEF, and those with HFbetterEF. Second, patient-perceived severity of dyspnea and fatigue and overall QOL rating were investigated within these HFdominant or not QOL subgroups and additionally according to distinct LVEF HF subtype. Questionnaires were designed to focus on 3 key areas:
METHODS
1) overall QOL; 2) symptom burden due to shortness of breath and fatigue; and 3) patients' perceived dominant overall limitations to their QOL status.
Separate vertical visual analogue scales (VAS) were used to assess overall QOL, ease of breathing, and Table 4 . Tables 1 and 2 . 
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